We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
168 hedge funds and large institutions have $2.41B invested in MyoKardia, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 68 increasing their positions, 35 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
128% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 18
94% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 35
37% more call options, than puts
Call options by funds: $5.53M | Put options by funds: $4.04M
36% more capital invested
Capital invested by funds: $1.77B → $2.41B (+$631M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
16% more funds holding
Funds holding: 145 → 168 (+23)
Holders
168
Holders Change
+23
Holders Change %
+15.86%
% of All Funds
3.64%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.13%
New
41
Increased
68
Reduced
35
Closed
18
Calls
$5.53M
Puts
$4.04M
Net Calls
+$1.49M
Net Calls Change
+$101K
Top Buyers
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$46.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$41.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.4M |
| 4 |
HM
HealthCor Management
New York
|
+$33.7M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$32.3M |
